International Assets Investment Management’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Buy
+201,260
New +$187K 0.01% 901
2026
Q1
Sell
-208,150
Closed -$182K 2326
2025
Q4
$182K Buy
208,150
+1,250
+0.6% +$1.35K 0.01% 842
2025
Q3
$155K Hold
206,900
0.01% 777
2025
Q2
$160K Hold
206,900
0.01% 782
2025
Q1
$114K Buy
206,900
+6,500
+3% +$4.75K 0.01% 745
2024
Q4
$186K Buy
200,400
+26,069
+15% +$27.1K 0.02% 755
2024
Q3
$200K Sell
174,331
-24,069
-12% -$23.6K 0.55% 40
2024
Q2
$196K Sell
198,400
-3,052
-2% -$3.32K 0.02% 719
2024
Q1
$214K Buy
201,452
+1,675
+0.8% +$1.87K 0.02% 654
2023
Q4
$270K Sell
199,777
-1,676
-0.8% -$2.62K 0.03% 530
2023
Q3
$449K Buy
201,453
+6,490
+3% +$15.9K 0.06% 295
2023
Q2
$507K Buy
194,963
+6,340
+3% +$10.5K 0.07% 270
2023
Q1
$226K Buy
188,623
+4,840
+3% +$7.6K 0.03% 442
2022
Q4
$300K Buy
183,783
+2,207
+1% +$3.35K 0.03% 470
2022
Q3
$223K Buy
181,576
+1,250
+0.7% +$1.53K 0.05% 345
2022
Q2
$182 Hold
180,326
0.02% 402
2022
Q1
$285K Buy
180,326
+6,815
+4% +$11.4K 0.05% 330
2021
Q4
$241K Buy
173,511
+2,935
+2% +$5.43K 0.04% 405
2021
Q3
$357K Buy
170,576
+8,750
+5% +$19.8K 0.06% 300
2021
Q2
$448K Sell
161,826
-116,026
-42% -$355K 0.08% 252
2021
Q1
$885K Buy
277,852
+157,076
+130% +$469K 0.08% 233
2020
Q4
$287K Buy
120,776
+27,365
+29% +$65.6K 0.05% 297
2020
Q3
$158K Buy
93,411
+60,724
+186% +$111K 0.04% 331
2020
Q2
$61K Buy
32,687
+18,548
+131% +$34.9K 0.01% 372
2020
Q1
$20K Buy
+14,139
New +$35.3K 0.01% 362

Other funds holding ONCY

International Assets Investment Management's ONCY Position: Q2 2026 in Review

International Assets Investment Management opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 201,260 shares worth $181K. The stake represents 0.01% of the portfolio and ranks #901 among its holdings. This is a return to the name: International Assets Investment Management previously reported a position in ONCY as recently as Q4 2025.

International Assets Investment Management first reported a position in ONCY in Q1 2020 and has held it in 25 quarters since. The position peaked at $885K in Q1 2021. 32 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • International Assets Investment Management held 201,260 shares of Oncolytics Biotech worth $181K as of Q2 2026.
  • Oncolytics Biotech was a new International Assets Investment Management position in Q2 2026.
  • Oncolytics Biotech made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #901 holding.
  • International Assets Investment Management first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 25 quarters since.
  • International Assets Investment Management's Oncolytics Biotech position peaked at $885K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.